Skip to main content
Top
Published in: Digestive Diseases and Sciences 1/2019

01-01-2019 | Original Article

Prevalence and Clinical Features of Celiac Disease in Healthy School-Aged Children

Authors: Omer Faruk Beser, Emine Gulluelli, Fugen Cullu Cokugras, Tulay Erkan, Tufan Kutlu, Rasit Vural Yagci, Firuze Erbek Alp, Gulten Ercal, Nuray Kepil, Mine Kucur, Northern Cyprus Celiac Study Group

Published in: Digestive Diseases and Sciences | Issue 1/2019

Login to get access

Abstract

Background/Aims

The aim of this study was to determine the prevalence of celiac disease (CD) in healthy school-aged children in the northern region of Cyprus and to investigate the existence of potential markers that may accompany CD. This is the first study to measure the prevalence of CD in the northern region of Cyprus.

Methods

This study included 3792 school-aged children who were between the ages of 6 and 10 years between January 2015 and October 2016. CD was screened using total serum IgA, IgA anti-tissue transglutaminase (tTG), and IgA antiendomysial (EMA) antibodies. Subjects with selective IgA deficiency were further tested for IgG-tTG. Small intestinal biopsies were performed on all subjects with tTG antibody positivity. Risk factors and symptoms related to CD were evaluated using questionnaires in both the CD and control groups.

Results

Of the 3792 subjects, 39 were antibody positive (IgA-tTG was positive only in 14 subjects, IgA-tTG plus IgA-EMA in 21 subjects, and IgG-tTG in 4 subjects). IgA deficiency was detected in 11 subjects (0.29%). IgG-tTG was positive in 4 subjects with IgA deficiency (36.3%). Intestinal biopsies were performed on 28 of the 39 seropositive subjects. The biopsy findings of 15 children were consistent with CD (IgA-tTG positive in 3, IgA-tTG and IgA-EMA positive in 10, and IgG-tTG positive in 2). Thus, biopsies confirmed CD in 1:256 children (0.39%).

Conclusions

Our study, which is the first study of school-aged children from the northern region of Cyprus, revealed that CD is a prevalent disease in this region.
Appendix
Available only for authorised users
Literature
1.
go back to reference Ludvigsson JF, Leffler DA, Bai JC, et al. The Oslo definitions for coeliac disease and related terms. Gut. 2013;62:43–52.CrossRef Ludvigsson JF, Leffler DA, Bai JC, et al. The Oslo definitions for coeliac disease and related terms. Gut. 2013;62:43–52.CrossRef
2.
go back to reference Sollid LM, Jabri B. Triggers and drivers of autoimmunity: lessons from coeliac disease. Nat Rev Immunol. 2013;13:294–302.CrossRef Sollid LM, Jabri B. Triggers and drivers of autoimmunity: lessons from coeliac disease. Nat Rev Immunol. 2013;13:294–302.CrossRef
3.
go back to reference Mishra A, Prakash S, Sreenivas V, et al. Structural and functional changes in the tight junctions of asymptomatic and serology-negative first-degree relatives of patients with celiac disease. J Clin Gastroenterol. 2016;50:551–560.CrossRef Mishra A, Prakash S, Sreenivas V, et al. Structural and functional changes in the tight junctions of asymptomatic and serology-negative first-degree relatives of patients with celiac disease. J Clin Gastroenterol. 2016;50:551–560.CrossRef
4.
go back to reference Maglio M, Tosco A, Auricchio R, et al. Intestinal deposits of anti-tissue transglutaminase IgA in childhood celiac disease. Dig Liver Dis. 2011;43:604–608.CrossRef Maglio M, Tosco A, Auricchio R, et al. Intestinal deposits of anti-tissue transglutaminase IgA in childhood celiac disease. Dig Liver Dis. 2011;43:604–608.CrossRef
5.
go back to reference Di Niro R, Mesin L, Zheng NY, et al. High abundance of plasma cells secreting transglutaminase 2-specific IgA autoantibodies with limited somatic hypermutation in celiac disease intestinal lesions. Nat Med. 2012;18:441–445.CrossRef Di Niro R, Mesin L, Zheng NY, et al. High abundance of plasma cells secreting transglutaminase 2-specific IgA autoantibodies with limited somatic hypermutation in celiac disease intestinal lesions. Nat Med. 2012;18:441–445.CrossRef
6.
go back to reference Wolf J, Petroff D, Richter T, et al. Validation of antibody-based strategies for diagnosis of pediatric celiac disease without biopsy. Gastroenterology. 2017;153:410–419.CrossRef Wolf J, Petroff D, Richter T, et al. Validation of antibody-based strategies for diagnosis of pediatric celiac disease without biopsy. Gastroenterology. 2017;153:410–419.CrossRef
8.
go back to reference Mustalahti K, Catassi C, Reunanen A, et al. The prevalence of celiac disease in Europe: results of a centralized, international mass screening project. Ann Med. 2010;42:587–595.CrossRef Mustalahti K, Catassi C, Reunanen A, et al. The prevalence of celiac disease in Europe: results of a centralized, international mass screening project. Ann Med. 2010;42:587–595.CrossRef
9.
go back to reference Husby S, Koletzko S, Korponay-Szabó IR, et al. European society for pediatric gastroenterology, hepatology, and nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr. 2012;54:136–160.CrossRef Husby S, Koletzko S, Korponay-Szabó IR, et al. European society for pediatric gastroenterology, hepatology, and nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr. 2012;54:136–160.CrossRef
10.
go back to reference Tio M, Cox MR, Eslick GD. Meta-analysis: coeliac disease and the risk of all-cause mortality, any malignancy and lymphoid malignancy. Aliment Pharmacol Ther. 2012;35:540–551.CrossRef Tio M, Cox MR, Eslick GD. Meta-analysis: coeliac disease and the risk of all-cause mortality, any malignancy and lymphoid malignancy. Aliment Pharmacol Ther. 2012;35:540–551.CrossRef
11.
go back to reference Dubé C, Rostom A, Sy R, et al. The prevalence of celiac disease in average-risk and at-risk Western European populations: a systematic review. Gastroenterology. 2005;128:57–67.CrossRef Dubé C, Rostom A, Sy R, et al. The prevalence of celiac disease in average-risk and at-risk Western European populations: a systematic review. Gastroenterology. 2005;128:57–67.CrossRef
12.
go back to reference World Health Organisation. Physical status: the use and interpretation of anthropometry. In: Report of a WHO Expert Committee. TRS No. 854. Geneva: World Health Organization; 1995. World Health Organisation. Physical status: the use and interpretation of anthropometry. In: Report of a WHO Expert Committee. TRS No. 854. Geneva: World Health Organization; 1995.
13.
go back to reference Marsh MN. Gluten, major histocompatibility complex, and the small intestine: a molecular and immunobiologic approach to the spectrum of gluten sensitivity ‘celiac sprue’. Gastroenterology. 1992;102:330–354.CrossRef Marsh MN. Gluten, major histocompatibility complex, and the small intestine: a molecular and immunobiologic approach to the spectrum of gluten sensitivity ‘celiac sprue’. Gastroenterology. 1992;102:330–354.CrossRef
14.
go back to reference Catassi C, Gatti S, Fasano A. The new epidemiology of celiac disease. J Pediatr Gastroenterol Nutr. 2014;59:7–9.CrossRef Catassi C, Gatti S, Fasano A. The new epidemiology of celiac disease. J Pediatr Gastroenterol Nutr. 2014;59:7–9.CrossRef
15.
go back to reference White LE, Merrick VM, Bannerman E, et al. The rising incidence of celiac disease in Scotland. Pediatrics. 2013;132:924–931.CrossRef White LE, Merrick VM, Bannerman E, et al. The rising incidence of celiac disease in Scotland. Pediatrics. 2013;132:924–931.CrossRef
16.
go back to reference Dalgic B, Sari S, Basturk B, et al. Prevalence of celiac disease in healthy Turkish school children. Am J Gastroenterol. 2011;106:1512–1517.CrossRef Dalgic B, Sari S, Basturk B, et al. Prevalence of celiac disease in healthy Turkish school children. Am J Gastroenterol. 2011;106:1512–1517.CrossRef
17.
go back to reference Ertekin V, Selimoğlu MA, Kardaş F, Aktaş E. Prevalence of celiac disease in Turkish children. J Clin Gastroenterol. 2005;39:689–691.CrossRef Ertekin V, Selimoğlu MA, Kardaş F, Aktaş E. Prevalence of celiac disease in Turkish children. J Clin Gastroenterol. 2005;39:689–691.CrossRef
18.
go back to reference Korponay-Szabó IR, Kovács JB, Czinner A, Gorácz G, Vámos A, Szabó T. High prevalence of silent celiac disease in preschool children screened with IgA/IgG antiendomysium antibodies. J Pediatr Gastroenterol Nutr. 1999;28:26–30.CrossRef Korponay-Szabó IR, Kovács JB, Czinner A, Gorácz G, Vámos A, Szabó T. High prevalence of silent celiac disease in preschool children screened with IgA/IgG antiendomysium antibodies. J Pediatr Gastroenterol Nutr. 1999;28:26–30.CrossRef
19.
go back to reference Castaño L, Blarduni E, Ortiz L, et al. Prospective population screening for celiac disease: high prevalence in the first 3 years of life. J Pediatr Gastroenterol Nutr. 2004;39:80–84.CrossRef Castaño L, Blarduni E, Ortiz L, et al. Prospective population screening for celiac disease: high prevalence in the first 3 years of life. J Pediatr Gastroenterol Nutr. 2004;39:80–84.CrossRef
20.
go back to reference Hill ID, Dirks MH, Liptak GS, et al. Guideline for the diagnosis and treatment of celiac disease in children: recommendations of the North American Society for pediatric gastroenterology, hepatology and nutrition. J Pediatr Gastroenterol Nutr. 2005;40:1–19.CrossRef Hill ID, Dirks MH, Liptak GS, et al. Guideline for the diagnosis and treatment of celiac disease in children: recommendations of the North American Society for pediatric gastroenterology, hepatology and nutrition. J Pediatr Gastroenterol Nutr. 2005;40:1–19.CrossRef
21.
go back to reference Stern M. Comparative evaluation of serologic tests for celiac disease: a European initiative toward standardization. J Pediatr Gastroenterol Nutr. 2000;31:513–519.CrossRef Stern M. Comparative evaluation of serologic tests for celiac disease: a European initiative toward standardization. J Pediatr Gastroenterol Nutr. 2000;31:513–519.CrossRef
22.
go back to reference Wong RC, Wilson RJ, Steele RH, Radford-Smith G, Adelstein S. A comparison of 13 guinea pig and human anti-tissue transglutaminase antibody ELISA kits. J Clin Pathol. 2002;55:488–494.CrossRef Wong RC, Wilson RJ, Steele RH, Radford-Smith G, Adelstein S. A comparison of 13 guinea pig and human anti-tissue transglutaminase antibody ELISA kits. J Clin Pathol. 2002;55:488–494.CrossRef
23.
go back to reference Toftedal P, Nielsen C, Madsen JT, Titlestad K, Husby S, Lillevang ST. Positive predictive value of serological diagnostic measures in celiac disease. Clin Chem Lab Med. 2010;48:685–691.CrossRef Toftedal P, Nielsen C, Madsen JT, Titlestad K, Husby S, Lillevang ST. Positive predictive value of serological diagnostic measures in celiac disease. Clin Chem Lab Med. 2010;48:685–691.CrossRef
24.
go back to reference Donaldson MR, Book LS, Leiferman KM, Zone JJ, Neuhausen SL. Strongly positive tissue transglutaminase antibodies are associated with Marsh 3 histopathology in adult and pediatric celiac disease. J Clin Gastroenterol. 2008;42:256–260.PubMed Donaldson MR, Book LS, Leiferman KM, Zone JJ, Neuhausen SL. Strongly positive tissue transglutaminase antibodies are associated with Marsh 3 histopathology in adult and pediatric celiac disease. J Clin Gastroenterol. 2008;42:256–260.PubMed
25.
go back to reference Fasano A, Berti I, Gerarduzzi T, et al. Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch Int Med. 2003;163:286–292.CrossRef Fasano A, Berti I, Gerarduzzi T, et al. Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch Int Med. 2003;163:286–292.CrossRef
26.
go back to reference Ivarsson A, Myléus A, Norström F, et al. Prevalence of childhood celiac disease and changes in infant feeding. Pediatrics. 2013;131:687–694.CrossRef Ivarsson A, Myléus A, Norström F, et al. Prevalence of childhood celiac disease and changes in infant feeding. Pediatrics. 2013;131:687–694.CrossRef
27.
go back to reference Roka V, Potamianos SP, Kapsoritakis AN, et al. Prevalence of coeliac disease in the adult population of central Greece. Eur J Gastroenterol Hepatol. 2007;19:982–987.CrossRef Roka V, Potamianos SP, Kapsoritakis AN, et al. Prevalence of coeliac disease in the adult population of central Greece. Eur J Gastroenterol Hepatol. 2007;19:982–987.CrossRef
28.
go back to reference Karagiozoglou-Lampoudi T, Zellos A, Vlahavas G, et al. Screening for coeliac disease in preschool greek children: the feasibility study of a community-based project. Acta Paediatr. 2013;102:749–754.CrossRef Karagiozoglou-Lampoudi T, Zellos A, Vlahavas G, et al. Screening for coeliac disease in preschool greek children: the feasibility study of a community-based project. Acta Paediatr. 2013;102:749–754.CrossRef
29.
30.
go back to reference Bardella MT, Fredella C, Saladino V, et al. Gluten intolerance: gender- and age-related differences in symptoms. Scand J Gastroenterol. 2005;40:15–19.CrossRef Bardella MT, Fredella C, Saladino V, et al. Gluten intolerance: gender- and age-related differences in symptoms. Scand J Gastroenterol. 2005;40:15–19.CrossRef
31.
go back to reference Szajewska H, Shamir R, Mearin L, et al. Gluten introduction and the risk of coeliac disease: a position paper by the European Society for pediatric gastroenterology, hepatology, and nutrition. J Pediatr Gastroenterol Nutr. 2016;62:507–513.CrossRef Szajewska H, Shamir R, Mearin L, et al. Gluten introduction and the risk of coeliac disease: a position paper by the European Society for pediatric gastroenterology, hepatology, and nutrition. J Pediatr Gastroenterol Nutr. 2016;62:507–513.CrossRef
33.
go back to reference Cannings-John R, Butler CC, Prout H, et al. A case-control study of presentations in general practice before diagnosis of coeliac disease. Br J Gen Pract. 2007;57:636–642.PubMedPubMedCentral Cannings-John R, Butler CC, Prout H, et al. A case-control study of presentations in general practice before diagnosis of coeliac disease. Br J Gen Pract. 2007;57:636–642.PubMedPubMedCentral
34.
go back to reference Toftedal P, Hansen DG, Nielsen C, Lillevang ST, Hansen TP, Husby S. Questionnaire-based case finding of celiac disease in a population of 8- to 9-year-old children. Pediatrics. 2010;125:518–524.CrossRef Toftedal P, Hansen DG, Nielsen C, Lillevang ST, Hansen TP, Husby S. Questionnaire-based case finding of celiac disease in a population of 8- to 9-year-old children. Pediatrics. 2010;125:518–524.CrossRef
35.
go back to reference Jansen M, van Zelm M, Groeneweg M, et al. The identification of celiac disease in asymptomatic children: the Generation R Study. J Gastroenterol. 2018;53:377–386.CrossRef Jansen M, van Zelm M, Groeneweg M, et al. The identification of celiac disease in asymptomatic children: the Generation R Study. J Gastroenterol. 2018;53:377–386.CrossRef
36.
go back to reference Rosen A, Sandstrom O, Carlsson A, et al. Usefulness of symptoms to screen for celiac disease. Pediatrics. 2014;133:211–218.CrossRef Rosen A, Sandstrom O, Carlsson A, et al. Usefulness of symptoms to screen for celiac disease. Pediatrics. 2014;133:211–218.CrossRef
37.
go back to reference Türkiye Beslenme ve Sağlık Araştırması 2010: Beslenme Durumu ve Alışkanlıklarının Değerlendirilmesi Sonuç Raporu. Ankara: Sağlık Bakanlığı Yayın; 2014;e466-72. Sağlık Bakanlığı Sağlık Araştırmaları Genel Müdürlüğü, Hacettepe Üniversitesi Sağlık Bilimleri Fakültesi Beslenme ve Diyetetik Bölümü, Ankara Numune Eğitim ve Araştırma Hastanesi. http://www.sagem.gov.tr/tbsa_beslenme_yayini.pdf Türkiye Beslenme ve Sağlık Araştırması 2010: Beslenme Durumu ve Alışkanlıklarının Değerlendirilmesi Sonuç Raporu. Ankara: Sağlık Bakanlığı Yayın; 2014;e466-72. Sağlık Bakanlığı Sağlık Araştırmaları Genel Müdürlüğü, Hacettepe Üniversitesi Sağlık Bilimleri Fakültesi Beslenme ve Diyetetik Bölümü, Ankara Numune Eğitim ve Araştırma Hastanesi. http://​www.​sagem.​gov.​tr/​tbsa_​beslenme_​yayini.​pdf
38.
go back to reference Wijnhoven TM, van Raaij JM, Spinelli A, et al. WHO European childhood obesity surveillance initiative: body mass index and level of overweight among 6-9-year-old children from school year 2007/2008 to school year 2009/2010. BMC Public Health. 2014;14:806.CrossRef Wijnhoven TM, van Raaij JM, Spinelli A, et al. WHO European childhood obesity surveillance initiative: body mass index and level of overweight among 6-9-year-old children from school year 2007/2008 to school year 2009/2010. BMC Public Health. 2014;14:806.CrossRef
39.
go back to reference Vivas S, de Morales JMR, Fernandez M, et al. Age-related clinical, serological, and histopathological features of celiac disease. Am. J. Gastroenterol. 2008;103:2360–2365.CrossRef Vivas S, de Morales JMR, Fernandez M, et al. Age-related clinical, serological, and histopathological features of celiac disease. Am. J. Gastroenterol. 2008;103:2360–2365.CrossRef
40.
go back to reference McGowan KE, Castiglione DA, Butzner JD. The changing face of childhood celiac disease in North America: impact of serological testing. Pediatrics. 2009;124:1572–1578.CrossRef McGowan KE, Castiglione DA, Butzner JD. The changing face of childhood celiac disease in North America: impact of serological testing. Pediatrics. 2009;124:1572–1578.CrossRef
41.
go back to reference Agardh D, Lee HS, Kurppa K, et al. Clinical features of celiac disease: a prospective birth cohort. Pediatrics. 2015;135:627–634.CrossRef Agardh D, Lee HS, Kurppa K, et al. Clinical features of celiac disease: a prospective birth cohort. Pediatrics. 2015;135:627–634.CrossRef
42.
go back to reference van Dommelen P, Grote FK, Oostdijk W, et al. Screening rules for growth to detect celiac disease: a case-control simulation study. BMC Pediatr. 2008;8:35.CrossRef van Dommelen P, Grote FK, Oostdijk W, et al. Screening rules for growth to detect celiac disease: a case-control simulation study. BMC Pediatr. 2008;8:35.CrossRef
43.
go back to reference Saari A, Harju S, Makitie O, et al. Systematic growth monitoring for the early detection of celiac disease in children. JAMA Pediatr. 2015;169:e1525.CrossRef Saari A, Harju S, Makitie O, et al. Systematic growth monitoring for the early detection of celiac disease in children. JAMA Pediatr. 2015;169:e1525.CrossRef
Metadata
Title
Prevalence and Clinical Features of Celiac Disease in Healthy School-Aged Children
Authors
Omer Faruk Beser
Emine Gulluelli
Fugen Cullu Cokugras
Tulay Erkan
Tufan Kutlu
Rasit Vural Yagci
Firuze Erbek Alp
Gulten Ercal
Nuray Kepil
Mine Kucur
Northern Cyprus Celiac Study Group
Publication date
01-01-2019
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 1/2019
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-018-5320-0

Other articles of this Issue 1/2019

Digestive Diseases and Sciences 1/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine